Cargando…

Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria

Pneumonia is one of the most common infections worldwide. Morbidity, mortality, and healthcare costs increase substantially when pneumonia is caused by multidrug-resistant Gram-negative bacteria (MDR-GNB). The ongoing spread of antimicrobial resistance has made treating MDR-GNB pneumonia increasingl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watkins, Richard R., Van Duin, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354321/ https://www.ncbi.nlm.nih.gov/pubmed/30755795 http://dx.doi.org/10.12688/f1000research.16517.2

Ejemplares similares

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2018)

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Michalopoulos, Argyris, et al.
Publicado: (2005)

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Mubareka, Samira, et al.
Publicado: (2005)

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
por: Wang, Chuanhai, et al.
Publicado: (2022)

Factors associated with survival of ICU patients with pneumonia caused by multidrug-resistant Gram-negative bacteria
por: Georgiadou, M, et al.
Publicado: (2015)

Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria
por: Tängdén, Thomas
Publicado: (2014)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
por: Bassetti, Matteo, et al.
Publicado: (2021)

Machine Learning and Multidrug-Resistant Gram-Negative Bacteria: An Interesting Combination for Current and Future Research
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
por: Frontiers Production Office,
Publicado: (2022)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic
por: Oliva, Alessandra, et al.
Publicado: (2018)

An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
por: Yusuf, Erlangga, et al.
Publicado: (2021)

Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia
por: Almangour, Thamer A., et al.
Publicado: (2020)

Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales
por: Vena, Antonio, et al.
Publicado: (2020)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Risk Factors of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in a Community Hospital in Rural Thailand
por: Ponyon, Jindanoot, et al.
Publicado: (2022)

New Multidrug Efflux Inhibitors for Gram-Negative Bacteria
por: Marshall, Robert L., et al.
Publicado: (2020)

Treatment of Infections Due to MDR Gram-Negative Bacteria
por: Bassetti, Matteo, et al.
Publicado: (2019)

Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?
por: Exner, Martin, et al.
Publicado: (2017)

Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria?
por: Salmi, Chanaz, et al.
Publicado: (2008)

Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia
por: Suwantarat, Nuntra, et al.
Publicado: (2016)

An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
por: Elliott, Alysha G., et al.
Publicado: (2020)

Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria
por: Gaudereto, Juliana Januario, et al.
Publicado: (2020)

Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
por: Silva, José Tiago, et al.
Publicado: (2021)

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)

OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria
por: Mandel, Shira, et al.
Publicado: (2021)

Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Vietnam: Antibiotic Resistance, Treatment Outcomes, and Colistin-Associated Adverse Effects
por: Vo, Thu Pham Minh, et al.
Publicado: (2022)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

Predatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens
por: Kadouri, Daniel E., et al.
Publicado: (2013)

Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in Virulence
por: Fernando, Dinesh M., et al.
Publicado: (2013)

Add-On Therapy with Ertapenem in Infections with Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience
por: Tanır Basaranoglu, Sevgen, et al.
Publicado: (2017)

Tridecaptin-inspired antimicrobial peptides with activity against multidrug-resistant Gram-negative bacteria
por: Ballantine, Ross D., et al.
Publicado: (2019)

Multidrug-Resistant and Clinically Relevant Gram-Negative Bacteria Are Present in German Surface Waters
por: Falgenhauer, Linda, et al.
Publicado: (2019)

Multidrug-Resistant Gram-Negative Bacteria Contaminating Raw Meat Sold in Accra, Ghana
por: Baah, Deric A., et al.
Publicado: (2022)

Multidrug-resistant gram-negative bacteria in patients with COVID-19: An epidemiological and clinical study
por: de Souza, Gleyce Hellen de Almeida, et al.
Publicado: (2023)

Editorial: Mobile genetic elements as dissemination drivers of multidrug-resistant Gram-negative bacteria
por: Nodari, Carolina Silva, et al.
Publicado: (2023)

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria
por: Mushtaq, Shazad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a5af4rf20vn3q1qqbuasqb7fiv